Amylin Pharmaceuticals Inc. (AMLN)

[north40000]

Icahn Issues Statement Regarding Amylin Pharmaceuticals



NEW YORK, April 25, 2012 /PRNewswire via COMTEX/ -- Carl C. Icahn today
announced that his affiliates had voluntarily dismissed their lawsuit against
Amylin Pharmaceuticals which had sought an extension of the deadline to nominate
directors at the 2012 annual meeting of shareholders. Mr. Icahn released the
following statement:

The decision to discontinue our lawsuit seeking to extend the director
nomination deadline was the result of discussions I had with Daniel Bradbury,
Amylin's chief executive officer, that we agreed would not be publicly
disclosed.

Mr. Icahn reiterated that he continues to strongly believe that the company
should be sold at this time.